XPR – Lifestyle Demo
Author:
Zenas BioPharma
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 16, 2026
Zenas BioPharma Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
March 16, 2026